Company: XERI
Filing Date: 2025-10-02
Form Type: 10-K
Source: 0001477932-25-007303
Chunk: 56

Company: XERIANT, INC.
Filing Date: 2025-10-02
Form: 10-K
Item: Item 1
Chunk 56
---
 value; 5,000,000,000 shares authorized; 695,746,625 and 524,853,304 shares issued and outstanding at June 30, 2025 and 2024, respectively  6,958   5,248 Common stock to be issued  97,900   51,950 Additional paid-in capital  22,410,416   20,899,187 Accumulated deficit  (28,338,606)  (26,708,915)Total stockholders’ deficit  (5,823,315)  (5,752,513)Non-controlling interest  (2,877,148)  (2,859,941)Total stockholders’ deficit  (8,700,463)  (8,612,454)Total liabilities and stockholders’ deficit $68,219  $713,005 

The accompanying notes are an integral part of these consolidated financial statements. 

 F-3Table of Contents

XERIANT, INC. 

CONSOLIDATED STATEMENTS OF OPERATIONS 

  For the years ended   June 30,   2025  2024 Operating expenses:      Consulting and advisory fees $327,991  $731,128 Related party consulting fees  438,000   388,000 General and administrative expenses  309,107   282,249 Professional fees  221,119   308,109 Research and development expense  69,274   196,422 Total operating expenses  1,365,491   1,905,908          Loss from operations  (1,365,491)  (1,905,908)         Other expenses:        Amortization of debt discount  (51,006)  (19,189)Interest expense  (225,566)  (1,183,885)Loss on extinguishment of debt  (4,835)  (20,298)Gain on extinguishment of debt  -   28,627 Change in fair value of convertible bridge loans  -   (2,448)Total other expense  (281,407)  (1,197,193)         Net loss before income tax expense  (1,